Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery

OBJECTIVE: Stereotactic radiosurgery (SRS) is routinely used to treat brain metastases from melanoma due to their radioresistant nature. The median survival for these patients is 4–6 months, according to earlier studies. The aim of this study was to evaluate prognostic factors that influence surviva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurosurg
Main Authors: Bian, Shelly X., Routman, David, Liu, Jonathan, Yang, Dongyun, Groshen, Susan, Zada, Gabriel, Trakul, Nicholas, Wong, Michael K., Yu, Cheng, Chang, Eric L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7469983/
https://ncbi.nlm.nih.gov/pubmed/27903181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2016.8.GKS161359
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados